Schafer Klaus 4

4 · Altimmune, Inc. · Filed Jun 22, 2022

Form 4

Period: 2022-06-20

Director

Transactions

Exercise/Conversion
Common Stock, par value $0.0001
2022-06-20$2.40/sh+159$382→ 9,119 total
Exercise/Conversion
Stock Options (option to buy)
2022-06-20−60→ 0 total
Exercise: $2.40Exp: 2022-12-30→ Common Stock, par value $0.0001 (60 underlying)
Exercise/Conversion
Stock Options (option to buy)
2022-06-20−60→ 0 total
Exercise: $2.40Exp: 2022-07-04→ Common Stock, par value $0.0001 (60 underlying)
Exercise/Conversion
Common Stock, par value $0.0001
2022-06-20$2.40/sh+60$144→ 8,960 total
Exercise/Conversion
Common Stock, par value $0.0001
2022-06-20$2.40/sh+60$144→ 9,179 total
Exercise/Conversion
Stock Options (option to buy)
2022-06-20−159→ 0 total
Exercise: $2.40Exp: 2022-07-04→ Common Stock, par value $0.0001 (159 underlying)

Footnotes (3)

[F1]This option was previously reported as covering 1,791 shares at an exercise price of $0.08 per share, but was adjusted to reflect a one-for-thirty reverse stock split reverse stock split that occurred on September 13, 2018.
[F2]This option was previously reported as covering 4,775 shares at an exercise price of $0.08 per share, but was adjusted to reflect a one-for-thirty reverse stock split reverse stock split that occurred on September 13, 2018.
[F3]This option is fully vested and exercisable as of the date hereof.

Documents

2 files